This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Accendatech, Nankai University. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2019
Title: Innovations of Hongxia Fan in Drug Technology
Introduction
Hongxia Fan is a notable inventor based in Tianjin, China. She has made significant contributions to the field of drug technology, particularly in the preparation of drugs using sesquiterpene lactone compounds and their derivatives. Her work focuses on developing treatments for serious health conditions, including rheumatoid arthritis and cancer.
Latest Patents
Hongxia Fan holds a patent titled "Uses of sesquiterpene lactone compounds and their derivatives in drugs preparation." This invention relates to the applications of these compounds in drug formulation, specifically targeting the treatment of rheumatoid arthritis and inhibiting cancer stem cells to combat various cancers. The patent highlights the potential of these compounds in advancing therapeutic options for patients.
Career Highlights
Throughout her career, Hongxia Fan has worked with reputable organizations, including Accendatech and Nankai University. Her experience in these institutions has allowed her to collaborate with other professionals in the field and contribute to innovative research and development.
Collaborations
Hongxia Fan has collaborated with notable colleagues, including Yue Chen and Quan Zhang. These partnerships have facilitated the exchange of ideas and expertise, further enhancing her contributions to drug technology.
Conclusion
Hongxia Fan's innovative work in drug technology exemplifies the impact of sesquiterpene lactone compounds in medical treatments. Her patent and collaborations reflect her commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile